Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |